TNF and rheumatoid arthritis: In addition, this significant decrease in the levels of plasma HS/H indicates that circulating HS/H seem to be useful as biomarkers for monitoring TNF-α inhibitors’ effectiveness, as well as disease activity, in patients with RA undergoing the anti-TNF-α therapy.